作者: Kathryn M. Brennan , Yunhong Bai , Michael E. Shy
DOI: 10.1016/J.NEULET.2015.01.059
关键词:
摘要: Abstract Inherited neuropathies known collectively as Charcot–Marie–Tooth disease are one of the most common inherited neurological conditions affecting ∼1 in 2500 people. A heterogenous disorder, CMT is divided into subtypes based on pattern inheritance and also by neurophysiological studies. Despite clinical similarities among patients with demyelinating CMT, it recognized that this group disorders both genetically phenotypically heterogenous. Understanding pathogenesis these requires an intimate knowledge normal myelin development homeostasis. Improvements genetic testing techniques over last 20 years have contributed majorly to identification specific genes, proteins, molecular pathways providing basis for understanding processes developing rational approaches therapy.